Corporate Sponsored Funding

PIVOT Center works with companies to thoroughly understand their R&D goals and match them to research goals of the appropriate faculty members at the University of Utah. PIVOT’s Corporate Engagement team works across all schools and units to facilitate partnerships and offer expertise on identifying opportunities that include grant funding, sponsored research and creating strategic corporate partnerships. PIVOT also provides guidance to faculty for successful stewardship. Please contact Sadhna Kohli (Director of Corporate Engagement) for more information regarding these opportunities, or if you have any questions.

---

Pfizer: 2021 Global Hemophilia ASPIRE
Amount: $70,000 to $90,000
Deadline: March 1^st, 2021

Projects that will be considered for Pfizer support will focus on the following areas:

1. Basic and Clinical Science of Gene Therapy for Hemophilia
2. Basic and Clinical Science of Tissue Factor Pathway Inhibitor (TFPI) and anti-TFPI monoclonal
3. Burden of disease: Clinical Hemophilia A and B

Note: Pfizer will not supply any study drug

Click here to learn more!

---

Pfizer: 2021 Global ANGPTL3 ASPIRE
Amount: $250,000
Deadline: LOI due March 12^th, 2021

The intent of this Request for Proposal (RFP) is to support basic science, pre-clinical research and clinical research through a competitive grants program that advances medical knowledge of the role of ANGPTL3 in health and disease.

Click here to learn more!

---

Pediatric Networks for the Human Cell Atlas
Amount: Varies, budget limit has not been set on a per project basis
Deadline: March 30, 2021

The Chan Zuckerberg Initiative invites applications for three-year collaborative projects for the generation of healthy, single-cell reference data from pediatric tissue samples for the Human Cell Atlas (HCA).

Click here to learn more!

---

Pfizer: Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Amount: $50,000
Deadline: April 8^th, 2021

Projects that will be considered for Pfizer support will focus on supporting the development of cardiac amyloid centers that provide leadership, best practices, support and/or training of HCPs within a multidisciplinary team environment in order to improve the quality of care for patients with ATTRCM.

Click here to learn more!

---

Pfizer: Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)
Amount: $150,000
Deadline: April 15^th, 2021

Projects that will be considered for Pfizer support will focus on improving the care of patients by:

• Educating [HCPs] to increase awareness and enable appropriate patient identification by closing knowledge gaps in disease epidemiology, pathophysiology, diagnosis, and emerging treatment paradigms.
• Addressing barriers to appropriate diagnosis and strategies that reduce burdens for patients and providers along the pathway to appropriate diagnosis
• Exploring strategies that empower patients to play an active role in understanding TTR amyloidosis and decision making regarding available diagnostic and treatment options
• Increasing awareness of the changing epidemiology of TTR amyloidosis with a focus on the prevalence of hereditary ATTR and wild-type ATTR subtypes as the science continues to evolve
• Increasing awareness of at risk and undiagnosed populations with TTR amyloidosis with a focus on improving strategies that facilitate the appropriate diagnosis of patients early in the disease course before overt cardiomyopathy has ensued [e.g. populations with electrical disturbances, valvular disease, orthopedic

Click here to learn more!

---

Pfizer: Pediatric Endocrinology Fellowship
Amount: $75,000
Deadline: June 1^st, 2021

The intent is to support institutions with fellowship programs for Pediatric Endocrinologists that have a strong focus on clinical practice, research, and education to further the understanding of short stature/growth failure

Click here to learn more!

---

Pfizer: 2021 Growth Hormone Research
Amount: $100,000
Deadline: June 1^st, 2021

Research projects that will be considered for Pfizer support will advance the medical knowledge of short stature.  Projects submitted may include:

• Diagnostics, early treatment, new treatment paradigms
• Clinical outcomes, quality of life, and patient reported outcomes
• Medication adherence research
• Translational or clinical research

Click here to learn more!

---

Pfizer: Acromegaly
Amount: $100,000
Deadline: June 1^st, 2021

Projects that will be considered for Pfizer support will focus on:

• Morbidity and mortality in Growth Hormone Excess
• Novel strategies including Quality of Life and Patient Reported Outcomes to evaluate and treat Growth Hormone Excess
• Early diagnosis and treatment of Growth Hormone Excess
• Pathophysiology of Growth Hormone Excess 

Click here to learn more!

---

Pfizer: Transthyretin Cardiac Amyloidosis Fellowship
Amount: $80,000
Deadline: June 15^th, 2021

The intent is to support institutions with fellowship programs for Cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of transthyretin cardiac amyloidosis. Grants will be available for both established and emerging Amyloid Centers of Excellence.

Click here to learn more!

---

List of Active Industrial Partnering Programs
Amount: Varies by program
Deadline: Varies by program

The PDF (in link below) has several new active RFPs from industry companies (covering all scientific fields) looking for collaboration with academic universities.

Click here to access the list and learn more!

 

Blog Search